ctrl K

Watchlist Price Alert

Design Therapeutics Inc. (DSGN)

NASDAQ: DSGN · Real-Time Price · USD

3.74

-0.13 (-3.36%)

At close: Jun 17, 2025, 2:14 PM

Design Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	226.00	834.00
Cost of Revenue	596K	537K	466K	129K	5K	1.65K
Gross Profit	n/a	-537K	-466K	-129K	-4.77K	-820
Operating Income	-62.38M	-78.19M	-67.59M	-35.83M	-8.33M	-1.91M
Interest Income	12.79M	n/a	n/a	n/a	n/a	n/a
Pretax Income	-49.59M	-66.86M	-63.31M	-35.53M	-8.28M	-2.05M
Net Income	-49.59M	-66.86M	-58.62M	-35.53M	-8.28M	-2.05M
Selling & General & Admin	18.03M	21.13M	18.98M	11.05M	2.5M	1.09M
Research & Development	44.35M	57.06M	48.61M	24.78M	6.06M	1.65M
Other Expenses	n/a	n/a	4.29M	298K	-226K	-834K
Operating Expenses	62.38M	78.19M	67.59M	35.83M	8.33M	1.91M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	78.19M	67.59M	35.83M	8.33M	1.91M
Income Tax Expense	n/a	n/a	-4.69M	-107.56K	-201.3K	-1.91K
Shares Outstanding (Basic)	56.59M	55.98M	55.71M	45.94M	27.19M	27.19M
Shares Outstanding (Diluted)	56.59M	55.98M	55.71M	45.94M	27.19M	27.19M
EPS (Basic)	-0.88	-1.19	-1.05	-0.77	-0.3	-0.08
EPS (Diluted)	-0.88	-1.19	-1.05	-0.77	-0.3	-0.08
EBITDA	-48.99M	-66.33M	-62.84M	-35.7M	-8.32M	-139K
EBIT	-49.59M	-66.86M	-63.31M	-35.53M	-8.28M	-2.05M
Depreciation & Amortization	596K	537K	466K	129K	5K	1.91M